Targeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signaling

Glioblastoma multiforme (GBM) is the most common human primary brain malignancy and has a dismal prognosis. Aggressive treatments using maximal surgical resection, radiotherapy, and temozolomide result in median survival of only 14.6 months in patients with GBM. Numerous clinical approaches using sm...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jin-Ku, Joo, Kyeung Min, Lee, Jeongwu, Yoon, Yeup, Nam, Do-Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211615/
https://www.ncbi.nlm.nih.gov/pubmed/25364264
http://dx.doi.org/10.2147/OTT.S36582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211615/
https://www.ncbi.nlm.nih.gov/pubmed/25364264
http://dx.doi.org/10.2147/OTT.S36582

Ejemplares similares